Dimera Incorporated
Records under this name other than patents Dimera Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Dimera Incorporated
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,182,833 | Method and kit for reducing the symptoms of peripheral vascular disease with topical progesterone Lapsed on the fee record Ended May 22, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2020 | From the USPTO record |
| US 6,056,972 | Method for reducing coronary artery reactivity Term ended Term ended Feb 6, 2018 · From the USPTO record | Term ended | Term ended Feb 6, 2018 | From the USPTO record |
| US 8,420,111 | Method and kit for reducing the symptoms of peripheral vascular disease Lapsed on the fee record Ended Apr 16, 2017 · From the USPTO record | Lapsed on the fee record | Ended Apr 16, 2017 | From the USPTO record |
| US 6,511,969 | Method for reducing coronary artery reactivity Lapsed on the fee record Ended Jan 28, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jan 28, 2015 | From the USPTO record |
| US 7,674,783 | Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease Lapsed on the fee record Ended Mar 9, 2014 · From the USPTO record | Lapsed on the fee record | Ended Mar 9, 2014 | From the USPTO record |
| US 7,572,780 | Method and kit for reducing the symptoms of peripheral vascular disease Lapsed on the fee record Ended Aug 11, 2013 · From the USPTO record | Lapsed on the fee record | Ended Aug 11, 2013 | From the USPTO record |
| US 6,602,487 | Methods and tests for producing and for inhibiting coronary artery vasospasms Lapsed on the fee record Ended Aug 5, 2011 · From the USPTO record | Lapsed on the fee record | Ended Aug 5, 2011 | From the USPTO record |